文献速递免疫规划慢病防控与筛查卫生政策与健康促进

美国成年人中人乳头瘤病毒疫苗接种的出生地差异

Nativity Disparities in Human Papillomavirus Vaccination Among U.S. Adults.
PubMed 文献 · Am J Prev Med · 2017-12-11

该研究利用2011至2015年美国国家健康访谈调查数据,分析15,967名18-32岁男性和23,794名18-35岁女性的HPV疫苗接种启动和完成情况。多因素logistic回归显示,外国出生男性和女性HPV疫苗接种启动的调整OR分别为0.63(95%CI=0.47,0.85)和0.57(95%CI=0.49,0.66),外国出生女性完成接种的调整OR为0.56(95%CI=0.46,0.69),均显著低于美国出生者。作者认为所纳入的人口学、社会经济和医疗保健因素不能完全解释观察到的差异,需未来研究探讨其他因素。

要点

  • 外国出生男性HPV疫苗接种启动的调整OR=0.63(95%CI=0.47,0.85),低于美国出生男性。
  • 外国出生女性HPV疫苗接种启动的调整OR=0.57(95%CI=0.49,0.66),低于美国出生女性。
  • 外国出生女性HPV疫苗接种完成的调整OR=0.56(95%CI=0.46,0.69),低于美国出生女性。

核心结论

  • 外国出生男性和女性HPV疫苗接种启动和完成的患病率均低于美国出生者,调整后外国出生男性和女性接种启动的OR分别为0.63和0.57,外国出生女性完成接种的OR为0.56。
  • 所纳入的人口学、社会经济和医疗保健因素似乎不能完全解释观察到的差异,未来需要研究其他可能促进出生地差异的因素。

研究设计与样本

  • 研究使用2011至2015年美国国家健康访谈调查数据,于2017年2月分析15,967名18-32岁男性和23,794名18-35岁女性。
  • 采用多因素logistic回归模型,分别评估出生地是否预测男性和女性的HPV疫苗接种启动(一剂及以上)和完成(三剂及以上),并调整人口学、社会经济和医疗保健因素。

主要发现

  • 与美国出生者相比,外国出生男性和女性HPV疫苗接种启动和完成的患病率均较低。
  • 调整协变量后,外国出生男性HPV疫苗接种启动的调整OR=0.63(95%CI=0.47,0.85),外国出生女性为OR=0.57(95%CI=0.49,0.66),均显著低于美国出生者。
  • 外国出生女性HPV疫苗接种完成的调整OR=0.56(95%CI=0.46,0.69),显著低于美国出生女性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Several studies have identified disparities in human papillomavirus (HPV)-related outcomes by nativity status (i.e., U.S.- versus foreign-born). However, few studies have explored whether vaccination differences exist by nativity status. Vaccination disparities have the potential to exacerbate HPV-related cancer disparities in the long term if left unaddressed. Therefore, the authors investigated whether there were significant differences in HPV vaccination initiation (one or more doses) and completion (three or more doses) between U.S.-born and foreign-born men and women. METHODS: Using the 2011 to 2015 waves of the National Health Interview Survey, data from 15,967 U.S. men aged 18-32 years and 23,794 U.S. women aged 18-35 years were analyzed in February 2017. Multivariable logistic regression models were fit to determine whether nativity status predicted (1) HPV vaccination initiation and (2) HPV vaccination completion separately among men and women after adjusting for demographic, socioeconomic, and healthcare factors. RESULTS: Compared with those born in the U.S., foreign-born men and women had lower prevalence of HPV vaccine initiation and completion. Furthermore, after controlling for covariates, foreign-born men (OR=0.63, 95% CI=0.47, 0.85) and women (OR=0.57, 95% CI=0.49, 0.66) had significantly lower adjusted odds of HPV vaccination initiation compared with their U.S.-born counterparts. Additionally, foreign-born women had significantly lower adjusted odds of HPV vaccination completion (OR=0.56, 95% CI=0.46, 0.69). CONCLUSIONS: The demographic, socioeconomic, and healthcare factors included in this study did not appear to account fully for observed disparities. Future research is needed to understand other factors that may contribute to nativity status disparities in HPV vaccination.

来源:Am J Prev Med,查看原文。版权归原作者所有。

引用

  1. Pérez AE, Agénor M, Gamarel KE, et al. Nativity Disparities in Human Papillomavirus Vaccination Among U.S. Adults. Am J Prev Med. 2017. PMID: 29241719. doi:10.1016/j.amepre.2017.10.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。